Ascendis Pharma
ASND
$225.63
Share price
-1.61%
Change (1 day)
14.98%
Change (1 year)
Categories
Revenue for Ascendis Pharma (ASND)
Revenue in 2024 (TTM): C$0.54 Billion
According to Ascendis Pharma
's latest financial reports the company's current revenue (TTM 
) is C$0.55 Billion. an increase over the revenue in the year 2023 that were of C$0.38 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ascendis Pharma from 2014 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | C$0.55 B | 44.05% |
| 2023 | C$0.38 B | 430.6% |
| 2022 | C$72.79 M | 539.77% |
| 2021 | C$11.37 M | 12.04% |
| 2020 | C$10.15 M | -48.16% |
| 2019 | C$19.59 M | 18.79% |
| 2018 | C$16.49 M | 649.16% |
| 2017 | C$2.2 M | -67.87% |
| 2016 | C$6.85 M | -44.99% |
| 2015 | C$12.45 M | -41.65% |
| 2014 | C$21.34 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | C$0.16 M | -99.97% | 🇺🇸 USA |
 | C$1.37 M | -99.75% | 🇩🇪 Germany |
 | C$0.22 B | -58.69% | 🇺🇸 USA |